Diker Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Diker Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48K	Hold	20,000	–	–	0.04%	45
2026 Q1	$31.2K	Buy	+20,000	New	+$29.1K	0.03%	41

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Diker Management's LXRX Position: Q2 2026 in Review

Diker Management held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 20,000 shares worth $48K. The position accounts for 0.04% of the portfolio, ranked #45.

Diker Management first reported a position in LXRX in Q1 2026 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Diker Management held 20,000 shares of Lexicon Pharmaceuticals worth $48K as of Q2 2026.
Diker Management left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
Lexicon Pharmaceuticals made up 0.04% of Diker Management's portfolio in Q2 2026, its #45 holding.
Diker Management first reported a position in Lexicon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Diker Management's 13F filing for Q2 2026, filed 14 Aug 2026.